Activities
Chronic CAD and PAD: Reducing Major Adverse Cardiovascular Events With Dual Pathway Inhibition Antithrombotic Therapy
0290-0000-20-281-H01-P
This activity will review guidelines for treatment of secondary prevention of CAD and PAD, as well as identification of when to recommend antithrombotic therapy, and counseling points pharmacists can provide to patients regarding lifestyle modifications for prevention of CAD and PAD.
2.00
Treating Anemia in Patients With Chronic Kidney Disease on Dialysis: The Role of the Pharmacist
0290-0000-20-318-L01-P
This live webinar will assist pharmacists caring for patients with CKD and anemia on dialysis in their traditional roles of medication management and patient monitoring and counseling.
11-18-2020
1.00
Influenza Vaccination: Opportunities for Pharmacists as Patient Advocates, Educators, and Administrators
0290-0000-20-276-H06-P
This activity provides pharmacists with insights into the status of influenza vaccination rates, as well as actionable strategies to improve vaccination outcomes among patients in future influenza seasons.
1.00
The Evolving Treatment Paradigm of HIV Therapy: Addressing Antiretroviral Tolerability and Barriers to Adherence
0290-0000-20-242-H02-P
This CE article will explore barriers to uptake and adherence of ART as well as inform about the complexities of HIV management in specific patient populations.
2.00